Brexpiprazole in the treatment of schizophrenia: pharmacology, efficacy, and side effects profile

Pharmacotherapy in Psychiatry and Neurology（2022）

引用 0|浏览4

暂无评分

摘要

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Bogusz K, Wojnar M. Brexpiprazole in the treatment of schizophrenia: pharmacology, efficacy, and side effects profile. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2022;38(2):107-118. doi:10.5114/fpn.2022.124607. APA Bogusz, K., & Wojnar, M. (2022). Brexpiprazole in the treatment of schizophrenia: pharmacology, efficacy, and side effects profile. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, 38(2), 107-118. https://doi.org/10.5114/fpn.2022.124607 Chicago Bogusz, Krzysztof, and Marcin Wojnar. 2022. "Brexpiprazole in the treatment of schizophrenia: pharmacology, efficacy, and side effects profile". Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii 38 (2): 107-118. doi:10.5114/fpn.2022.124607. Harvard Bogusz, K., and Wojnar, M. (2022). Brexpiprazole in the treatment of schizophrenia: pharmacology, efficacy, and side effects profile. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, 38(2), pp.107-118. https://doi.org/10.5114/fpn.2022.124607 MLA Bogusz, Krzysztof et al. "Brexpiprazole in the treatment of schizophrenia: pharmacology, efficacy, and side effects profile." Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, vol. 38, no. 2, 2022, pp. 107-118. doi:10.5114/fpn.2022.124607. Vancouver Bogusz K, Wojnar M. Brexpiprazole in the treatment of schizophrenia: pharmacology, efficacy, and side effects profile. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2022;38(2):107-118. doi:10.5114/fpn.2022.124607.

查看译文

关键词

brexpiprazole,schizophrenia,pharmacology,side effects

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要